DUBLIN, Nov. 14, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the winner of the Extracorporeal Immunomodulation Award (EIA). The award recognizes a ...
AEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
A special ergonomics display will be available, highlighting the benefits of the POWERSEAL device design and the ongoing need for ergonomically friendly devices. Booth visitors can see how the "Ease ...
The following is a summary of “Vascular Complications After Venoarterial Extracorporeal Membrane Oxygenation Support: A CT Study,” published in the November 2024 issue of Critical Care by Djavidi et ...